Role of cardiolipin alterations in mitochondrial dysfunction and disease.

By A. Chicco, G. Sparagna. American Journal of Physiology - Cell Physiology, 2007

642 citations recorded by the source corpus.

Subfields: Clinical Biochemistry, Molecular Biology

View Paper: https://www.semanticscholar.org/paper/7f04b7c68b747a73a472e387f8cb5fa8dd22a868

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Clinical Biochemistry

1. T. Langer

In Molecular Biology

1. T. Langer

Citations in the corpus

• Mitochondrial function as a therapeutic target in heart failure (2016, neutral): “Cardiolipin decrements are observed in both paediatric 150 and adult 151,152 patients with HF. Cardiolipin is essential for the activity of ETC complexes, membrane transporters, mitochondrial ion homeostasis, and ROS production 153 .”
• Making heads or tails of phospholipids in mitochondria (2011, background): “Indeed, both altered phospholipid levels and phospholipid damage have been linked to a variety of human disease states (Chicco and Sparagna, 2007; Joshi et al., 2009).”